FI107015B - Kasvistanolirasvahappoestereiden seos ja sen käyttö sekä elintarvike - Google Patents
Kasvistanolirasvahappoestereiden seos ja sen käyttö sekä elintarvike Download PDFInfo
- Publication number
- FI107015B FI107015B FI963126A FI963126A FI107015B FI 107015 B FI107015 B FI 107015B FI 963126 A FI963126 A FI 963126A FI 963126 A FI963126 A FI 963126A FI 107015 B FI107015 B FI 107015B
- Authority
- FI
- Finland
- Prior art keywords
- fatty acid
- cholesterol
- stanol
- sitostanol
- acid ester
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 98
- 235000013305 food Nutrition 0.000 title claims abstract description 27
- 235000014113 dietary fatty acids Nutrition 0.000 title claims description 79
- 229930195729 fatty acid Natural products 0.000 title claims description 79
- 239000000194 fatty acid Substances 0.000 title claims description 79
- -1 fatty acid esters Chemical class 0.000 title claims description 76
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 claims abstract description 88
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 83
- LGJMUZUPVCAVPU-JFBKYFIKSA-N Sitostanol Natural products O[C@@H]1C[C@H]2[C@@](C)([C@@H]3[C@@H]([C@H]4[C@@](C)([C@@H]([C@@H](CC[C@H](C(C)C)CC)C)CC4)CC3)CC2)CC1 LGJMUZUPVCAVPU-JFBKYFIKSA-N 0.000 claims abstract description 50
- VGSSUFQMXBFFTM-UHFFFAOYSA-N (24R)-24-ethyl-5alpha-cholestane-3beta,5,6beta-triol Natural products C1C(O)C2(O)CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 VGSSUFQMXBFFTM-UHFFFAOYSA-N 0.000 claims abstract description 49
- ARYTXMNEANMLMU-UHFFFAOYSA-N 24alpha-methylcholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(C)C(C)C)C1(C)CC2 ARYTXMNEANMLMU-UHFFFAOYSA-N 0.000 claims abstract description 48
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 claims description 39
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 claims description 38
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 claims description 38
- 235000000431 campesterol Nutrition 0.000 claims description 38
- 235000002378 plant sterols Nutrition 0.000 claims description 37
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 claims description 32
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 claims description 31
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 claims description 30
- 229950005143 sitosterol Drugs 0.000 claims description 30
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 claims description 29
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 claims description 29
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 claims description 29
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 claims description 29
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 claims description 29
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 claims description 29
- 235000015500 sitosterol Nutrition 0.000 claims description 29
- 210000002966 serum Anatomy 0.000 claims description 28
- 235000005911 diet Nutrition 0.000 claims description 25
- 230000037213 diet Effects 0.000 claims description 20
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 7
- ARYTXMNEANMLMU-ATEDBJNTSA-N campestanol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]2(C)CC1 ARYTXMNEANMLMU-ATEDBJNTSA-N 0.000 abstract description 38
- LGJMUZUPVCAVPU-HRJGVYIJSA-N stigmastanol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]2(C)CC1 LGJMUZUPVCAVPU-HRJGVYIJSA-N 0.000 abstract description 36
- 239000003925 fat Substances 0.000 abstract description 22
- 239000003921 oil Substances 0.000 abstract description 11
- 230000032050 esterification Effects 0.000 abstract description 8
- 238000005886 esterification reaction Methods 0.000 abstract description 8
- 229930182558 Sterol Natural products 0.000 description 53
- 235000003702 sterols Nutrition 0.000 description 53
- 150000003432 sterols Chemical class 0.000 description 52
- 235000013310 margarine Nutrition 0.000 description 36
- 235000012000 cholesterol Nutrition 0.000 description 25
- 239000003264 margarine Substances 0.000 description 25
- 239000008158 vegetable oil Substances 0.000 description 24
- 235000015112 vegetable and seed oil Nutrition 0.000 description 23
- 150000002148 esters Chemical class 0.000 description 22
- 239000003784 tall oil Substances 0.000 description 22
- 238000010521 absorption reaction Methods 0.000 description 18
- 235000019197 fats Nutrition 0.000 description 18
- 238000000034 method Methods 0.000 description 18
- 230000000694 effects Effects 0.000 description 16
- 229920006395 saturated elastomer Polymers 0.000 description 15
- 241000196324 Embryophyta Species 0.000 description 12
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 10
- 239000003054 catalyst Substances 0.000 description 10
- 238000005984 hydrogenation reaction Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 230000008569 process Effects 0.000 description 9
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- 238000008214 LDL Cholesterol Methods 0.000 description 7
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 7
- 239000003529 anticholesteremic agent Substances 0.000 description 7
- 229940127226 anticholesterol agent Drugs 0.000 description 7
- 150000004665 fatty acids Chemical class 0.000 description 7
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 7
- 235000016831 stigmasterol Nutrition 0.000 description 7
- 229940032091 stigmasterol Drugs 0.000 description 7
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical class CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000001906 cholesterol absorption Effects 0.000 description 5
- 230000000378 dietary effect Effects 0.000 description 5
- 235000013367 dietary fats Nutrition 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 235000014107 unsaturated dietary fats Nutrition 0.000 description 5
- 241000282414 Homo sapiens Species 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- 230000003389 potentiating effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 150000003431 steroids Chemical class 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 description 3
- 240000002129 Malva sylvestris Species 0.000 description 3
- 235000006770 Malva sylvestris Nutrition 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 235000019484 Rapeseed oil Nutrition 0.000 description 3
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 description 3
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 3
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000004420 brassicasterol Nutrition 0.000 description 3
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 description 3
- 235000013351 cheese Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000005822 corn Nutrition 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 230000000704 physical effect Effects 0.000 description 3
- 238000011020 pilot scale process Methods 0.000 description 3
- 229940033331 soy sterol Drugs 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 235000019871 vegetable fat Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241001125671 Eretmochelys imbricata Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 108010010234 HDL Lipoproteins Proteins 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 206010063985 Phytosterolaemia Diseases 0.000 description 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
- 235000011613 Pinus brutia Nutrition 0.000 description 2
- 241000018646 Pinus brutia Species 0.000 description 2
- 208000002227 Sitosterolemia Diseases 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008094 contradictory effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 239000008157 edible vegetable oil Substances 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 235000019387 fatty acid methyl ester Nutrition 0.000 description 2
- 235000021149 fatty food Nutrition 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 238000005809 transesterification reaction Methods 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- LGJMUZUPVCAVPU-ANOYILKDSA-N (3s,8r,9s,10s,13r,14s,17r)-17-[(2r,5s)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-ol Chemical compound C1CC2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@H](CC)C(C)C)[C@@]1(C)CC2 LGJMUZUPVCAVPU-ANOYILKDSA-N 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 239000004267 EU approved acidity regulator Substances 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 208000035977 Rare disease Diseases 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 206010048215 Xanthomatosis Diseases 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 238000003965 capillary gas chromatography Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000008162 cooking oil Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 239000000383 hazardous chemical Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000000099 in vitro assay Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003050 macronutrient Effects 0.000 description 1
- 235000021073 macronutrients Nutrition 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 235000010746 mayonnaise Nutrition 0.000 description 1
- 239000008268 mayonnaise Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- LGJMUZUPVCAVPU-GJAZBXDESA-N poriferastan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CC[C@H](CC)C(C)C)[C@@]2(C)CC1 LGJMUZUPVCAVPU-GJAZBXDESA-N 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000014438 salad dressings Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 125000002328 sterol group Chemical group 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
- A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Edible Oils And Fats (AREA)
- Saccharide Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Seasonings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (35)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI963126A FI107015B (fi) | 1996-08-09 | 1996-08-09 | Kasvistanolirasvahappoestereiden seos ja sen käyttö sekä elintarvike |
| IL12845896A IL128458A (en) | 1996-08-09 | 1996-09-02 | Stanol composition and the use thereof |
| CA002262600A CA2262600C (en) | 1996-08-09 | 1996-09-02 | Stanol composition and the use thereof |
| CNB961804068A CN1165312C (zh) | 1996-08-09 | 1996-09-02 | 加氢甾醇组合物及其应用 |
| JP10509427A JP2000513730A (ja) | 1996-08-09 | 1996-09-02 | スタノール組成物及びその用途 |
| EP04011018A EP1452180A1 (en) | 1996-08-09 | 1996-09-02 | Stanol composition and the use thereof |
| AU68230/96A AU734418B2 (en) | 1996-08-09 | 1996-09-02 | Stanol composition and the use thereof |
| NZ334496A NZ334496A (en) | 1996-08-09 | 1996-09-02 | Serum cholesterol lowering composition of sitostanol and campestanol fatty acid esters for addition to fat-containing foods |
| PT96928481T PT871451E (pt) | 1996-08-09 | 1996-09-02 | Composicao de estanol e a respectiva utilizacao |
| EEP199900040A EE03747B1 (et) | 1996-08-09 | 1996-09-02 | Stanooli kompositsioon ja selle kasutamine |
| SI9620141A SI9620141B (sl) | 1996-08-09 | 1996-09-02 | Stanolni sestavki in njihova uporaba |
| PL96331515A PL331515A1 (en) | 1996-08-09 | 1996-09-02 | Stannoles containing composition and application thereof |
| UA99021088A UA66763C2 (en) | 1996-08-09 | 1996-09-02 | Stanol composition (variants) and food product containing stanol composition |
| DE69632481T DE69632481T3 (de) | 1996-08-09 | 1996-09-02 | Zusammensetzung enthaltend pflanzliche Stanol-Ester und ihre Verwendung zur Senkung des Cholesterin-Spiegels |
| DK96928481T DK0871451T4 (da) | 1996-08-09 | 1996-09-02 | Sammensætning omfattende plantestanolestere og anvendelse deraf til sænkning af serumcholesterol |
| CZ1999346A CZ290903B6 (cs) | 1996-08-09 | 1996-09-02 | Kompozice esterů rostlinných stanolů s mastnými kyselinami a její pouľití a potravinářská substance ji obsahující |
| HU0001020A HU228301B1 (en) | 1996-08-09 | 1996-09-02 | Stanol composition and the use thereof |
| ES96928481T ES2220986T5 (es) | 1996-08-09 | 1996-09-02 | Composicion que comprende esteres de estanol vegetal y el uso del mismo para reducir el colesterol en el suero. |
| KR10-1999-7001057A KR100440640B1 (ko) | 1996-08-09 | 1996-09-02 | 스타놀 조성물 및 이것의 사용방법 |
| AT96928481T ATE266408T1 (de) | 1996-08-09 | 1996-09-02 | Zusammensetzung enthaltend pflanzliche stanol- ester und ihre verwendung zur senkung des cholesterin-spiegels |
| PCT/FI1996/000465 WO1998006405A1 (en) | 1996-08-09 | 1996-09-02 | Stanol composition and the use thereof |
| SK112-99A SK285849B6 (sk) | 1996-08-09 | 1996-09-02 | Kompozícia obsahujúca estery rastlinných stanolovs mastnými kyselinami, jej použitie a potravinárska substancia s jej obsahom |
| BRPI9612693A BRPI9612693B8 (pt) | 1996-08-09 | 1996-09-02 | composição de estanol e uso da mesma |
| EP96928481A EP0871451B2 (en) | 1996-08-09 | 1996-09-02 | Composition comprising plant stanol esters and the use thereof for lowering the serum cholesterol |
| ZA967616A ZA967616B (en) | 1996-08-09 | 1996-09-10 | Stanol composition and the thereof |
| NO19990559A NO326262B1 (no) | 1996-08-09 | 1999-02-05 | Plantestanolfettsyrestersammensetninger omfattende sitostanolfettsyrester og campestanolfettsyrester, matvaresubstans inneholdende denne og anvendelser derav. |
| LT99-018A LT4649B (lt) | 1996-08-09 | 1999-02-26 | Stanolio kompozicija ir jos panaudojimas |
| LVP-99-41A LV12307B (en) | 1996-08-09 | 1999-03-09 | Stanol composition and the use thereof |
| US10/223,633 US20030104035A1 (en) | 1996-08-09 | 2002-08-20 | Stanol composition and the use thereof |
| JP2003405151A JP4554915B2 (ja) | 1996-08-09 | 2003-12-03 | スタノール組成物及びその用途 |
| US11/070,208 US20050147729A1 (en) | 1996-08-09 | 2005-03-03 | Stanol composition and the use thereof |
| US11/819,379 US20070249574A1 (en) | 1996-08-09 | 2007-06-27 | Stanol composition and the use thereof |
| JP2009024241A JP2009102421A (ja) | 1996-08-09 | 2009-02-04 | スタノール組成物及びその用途 |
| US12/731,907 US8349821B2 (en) | 1996-08-09 | 2010-03-25 | Stanol composition and the use thereof |
| US13/718,637 US8853191B2 (en) | 1996-08-09 | 2012-12-18 | Stanol composition and the use thereof |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI963126A FI107015B (fi) | 1996-08-09 | 1996-08-09 | Kasvistanolirasvahappoestereiden seos ja sen käyttö sekä elintarvike |
| FI963126 | 1996-08-09 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI963126A0 FI963126A0 (fi) | 1996-08-09 |
| FI963126L FI963126L (fi) | 1998-02-10 |
| FI107015B true FI107015B (fi) | 2001-05-31 |
Family
ID=8546469
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI963126A FI107015B (fi) | 1996-08-09 | 1996-08-09 | Kasvistanolirasvahappoestereiden seos ja sen käyttö sekä elintarvike |
Country Status (27)
| Country | Link |
|---|---|
| EP (2) | EP1452180A1 (enExample) |
| JP (3) | JP2000513730A (enExample) |
| KR (1) | KR100440640B1 (enExample) |
| CN (1) | CN1165312C (enExample) |
| AT (1) | ATE266408T1 (enExample) |
| AU (1) | AU734418B2 (enExample) |
| BR (1) | BRPI9612693B8 (enExample) |
| CA (1) | CA2262600C (enExample) |
| CZ (1) | CZ290903B6 (enExample) |
| DE (1) | DE69632481T3 (enExample) |
| DK (1) | DK0871451T4 (enExample) |
| EE (1) | EE03747B1 (enExample) |
| ES (1) | ES2220986T5 (enExample) |
| FI (1) | FI107015B (enExample) |
| HU (1) | HU228301B1 (enExample) |
| IL (1) | IL128458A (enExample) |
| LT (1) | LT4649B (enExample) |
| LV (1) | LV12307B (enExample) |
| NO (1) | NO326262B1 (enExample) |
| NZ (1) | NZ334496A (enExample) |
| PL (1) | PL331515A1 (enExample) |
| PT (1) | PT871451E (enExample) |
| SI (1) | SI9620141B (enExample) |
| SK (1) | SK285849B6 (enExample) |
| UA (1) | UA66763C2 (enExample) |
| WO (1) | WO1998006405A1 (enExample) |
| ZA (1) | ZA967616B (enExample) |
Families Citing this family (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU664827B2 (en) | 1991-05-03 | 1995-12-07 | Raisio Benecol Ltd. | A substance for lowering high cholesterol level in serum and a method for preparing the same |
| US6544973B1 (en) | 1995-07-28 | 2003-04-08 | Raisio Benecol Ltd. | Substance for lowering high cholesterol level in serum and methods for preparing and using the same |
| US6642268B2 (en) | 1994-09-13 | 2003-11-04 | G.D. Searle & Co. | Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors |
| US6262277B1 (en) | 1994-09-13 | 2001-07-17 | G.D. Searle And Company | Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| US20030104035A1 (en) | 1996-08-09 | 2003-06-05 | Raisio Benecol Ltd. | Stanol composition and the use thereof |
| US6929816B2 (en) | 1998-01-21 | 2005-08-16 | Raisio Benecol Ltd. | Fat compositions for use in food |
| UA69378C2 (uk) * | 1996-11-04 | 2004-09-15 | Райзіо Бенекол Лтд. | Текстуруюча композиція, текстуруючий агент, харчовий продукт, жирові суміші та способи їх одержання |
| FI107538B (fi) * | 1997-02-26 | 2001-08-31 | Raisio Benecol Oy | Menetelmä stanoliesterien valmistamiseksi |
| ES2222553T3 (es) * | 1997-08-22 | 2005-02-01 | Unilever N.V. | Producto alimenticio a base de grasa que comprende esteroles. |
| DE69826592T2 (de) * | 1997-08-22 | 2006-02-23 | Unilever N.V. | Verfahren zur Herstellung von Stanolestern |
| ES2272882T3 (es) | 1997-08-22 | 2007-05-01 | Unilever N.V. | Composciones que comprenden estanol. |
| EP0897971B1 (en) * | 1997-08-22 | 2004-11-03 | Unilever N.V. | Stanol ester composition |
| EP1440619B1 (en) * | 1997-08-22 | 2006-11-02 | Unilever N.V. | Fat based food products comprising sterols |
| ES2231940T3 (es) * | 1997-08-22 | 2005-05-16 | Unilever N.V. | Composicion de esteres de estanol. |
| FI974648A7 (fi) | 1997-09-09 | 1999-05-06 | Raisio Benecol Oy | Hydroksihappo-, maitohappo- ja hydroksialkanoaattiesterit ja niiden käyttö |
| EP1066313A1 (de) * | 1998-03-23 | 2001-01-10 | Cognis Deutschland GmbH | Verfahren zur herstellung von stanolen |
| US6025348A (en) * | 1998-04-30 | 2000-02-15 | Kao Corporation | Oil and fat composition containing phytosterol |
| US6123978A (en) | 1998-08-31 | 2000-09-26 | Mcneil-Ppc, Inc. | Stable salad dressings |
| US6277431B1 (en) * | 1998-10-14 | 2001-08-21 | Redeem, Inc. | Anticholesterolemic edible oil |
| FI115527B (fi) * | 1998-10-16 | 2005-05-31 | Upm Kymmene Oyj | Kasvisterolijohdannaisten käyttö ja niitä sisältäviä tuotteita |
| ID24148A (id) * | 1998-11-26 | 2000-07-13 | Hoffmann La Roche | Turunan-turunan fitostfrol dan/atau fitostanol |
| US6113972A (en) * | 1998-12-03 | 2000-09-05 | Monsanto Co. | Phytosterol protein complex |
| EP1340508A1 (en) | 1998-12-23 | 2003-09-03 | G.D. Searle LLC. | Combinations of cholesteryl ester transfer protein inhibitors and nicotinic acid derivatives for cardiovascular indications |
| AU3228100A (en) | 1999-02-10 | 2000-08-29 | Eastman Chemical Company | Corn fiber for the production of advanced chemicals and materials |
| BR0010597A (pt) | 1999-04-12 | 2002-02-13 | Monsanto Technology Llc | Plantas transgênicas contendo nìveis alterados de compostos esterol e tocoferóis |
| FI991533L (fi) * | 1999-07-05 | 2001-01-06 | Sohkar Oy | Menetelmä orgaanisten aineiden käsittelemiseksi |
| US6998501B1 (en) | 1999-08-30 | 2006-02-14 | Ocean Nutrition Canada Limited | Nutritional supplement for lowering serum triglyceride and cholesterol levels |
| US7157619B1 (en) | 1999-08-30 | 2007-01-02 | Monsanto Technology, L.L.C. | Plant sterol acyltransferases |
| AU6813700A (en) * | 1999-08-30 | 2001-03-26 | Ocean Nutrition Canada Ltd. | A nutritional supplement for lowering serum triglyceride and cholesterol levels |
| US6677327B1 (en) | 1999-11-24 | 2004-01-13 | Archer-Daniels-Midland Company | Phytosterol and phytostanol compositions |
| ATE323714T1 (de) * | 2000-01-21 | 2006-05-15 | Forbes Medi Tech Inc | Krystalline zusammensetzungen enthaltend phytosterole und phytostanole oder derivate davon |
| EP1252137A1 (en) | 2000-01-28 | 2002-10-30 | The Procter & Gamble Company | Palatable arginine compounds and uses thereof for cardiovascular health |
| DK1121928T3 (da) * | 2000-01-31 | 2008-03-17 | Haerting S A | Sammensætninger indeholdende phytosterol- og policosanolestere af fedtsyrer til reduktion af niveauet af blodcholesterol og -triglycerider |
| JP4970690B2 (ja) | 2000-04-14 | 2012-07-11 | マース インコーポレーテッド | 血管の健康状態を改善するための組成物および方法 |
| FI20010780A0 (fi) * | 2001-04-12 | 2001-04-12 | Raisio Benecol Oy | Parannetut koostumukset |
| CA2471639A1 (en) | 2002-01-17 | 2003-07-31 | Pharmacia Corporation | Novel alkyl/aryl hydroxy or keto thiepines. |
| US20080182801A1 (en) | 2003-12-22 | 2008-07-31 | Btg International Limited | Core 2 glcnac-t inhibitors |
| GB0513881D0 (en) | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors III |
| GB0329667D0 (en) | 2003-12-22 | 2004-01-28 | King S College London | Core 2 GlcNAc-T inhibitor |
| US8158184B2 (en) | 2004-03-08 | 2012-04-17 | Bunge Oils, Inc. | Structured lipid containing compositions and methods with health and nutrition promoting characteristics |
| GB0513888D0 (en) | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors II |
| GB0513883D0 (en) | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Diagnosis of Atherosclerosis |
| IE20060710A1 (en) * | 2005-09-28 | 2007-07-25 | Alltracel Dev Services Ltd | Use of polyanhydroglucronic acid |
| JP2009521416A (ja) * | 2005-12-20 | 2009-06-04 | フォーブス メディ−テック インコーポレーテッド | 水相中にエステル化されていないフィトステロールを含むエマルジョン |
| US20070148311A1 (en) | 2005-12-22 | 2007-06-28 | Bunge Oils, Inc. | Phytosterol esterification product and method of make same |
| AU2007222697B2 (en) * | 2006-03-08 | 2012-07-05 | Cognis Ip Management Gmbh | Powder containing sterol |
| DE102006041302A1 (de) * | 2006-03-08 | 2007-09-13 | Cognis Ip Management Gmbh | Sterolester mit kurzkettigen Fettsäuren |
| US20080124387A1 (en) | 2006-11-27 | 2008-05-29 | Kapac, Llc | Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients |
| FI123374B (fi) | 2011-03-25 | 2013-03-15 | Ravintoraisio Oy | Uusi syötävä koostumus |
| PL3287014T3 (pl) * | 2016-08-22 | 2020-08-24 | Verbio Vereinigte Bioenergie Ag | Sposób wytwarzania kompozycji fitosteroli-fitostanoli |
| WO2021170873A1 (en) * | 2020-02-27 | 2021-09-02 | Basf Se | Composition for the treatment of (pre)hypercholesterolemia and/or associated morbidities thereto |
| GB202110358D0 (en) * | 2021-07-19 | 2021-09-01 | Meda Pharma S P A | Composition |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU664827B2 (en) * | 1991-05-03 | 1995-12-07 | Raisio Benecol Ltd. | A substance for lowering high cholesterol level in serum and a method for preparing the same |
| US5244887A (en) * | 1992-02-14 | 1993-09-14 | Straub Carl D | Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof |
-
1996
- 1996-08-09 FI FI963126A patent/FI107015B/fi not_active IP Right Cessation
- 1996-09-02 WO PCT/FI1996/000465 patent/WO1998006405A1/en not_active Ceased
- 1996-09-02 DE DE69632481T patent/DE69632481T3/de not_active Expired - Lifetime
- 1996-09-02 PL PL96331515A patent/PL331515A1/xx unknown
- 1996-09-02 IL IL12845896A patent/IL128458A/en not_active IP Right Cessation
- 1996-09-02 SI SI9620141A patent/SI9620141B/sl active Search and Examination
- 1996-09-02 PT PT96928481T patent/PT871451E/pt unknown
- 1996-09-02 AU AU68230/96A patent/AU734418B2/en not_active Expired
- 1996-09-02 EE EEP199900040A patent/EE03747B1/xx not_active IP Right Cessation
- 1996-09-02 EP EP04011018A patent/EP1452180A1/en not_active Withdrawn
- 1996-09-02 EP EP96928481A patent/EP0871451B2/en not_active Expired - Lifetime
- 1996-09-02 CZ CZ1999346A patent/CZ290903B6/cs not_active IP Right Cessation
- 1996-09-02 NZ NZ334496A patent/NZ334496A/xx not_active IP Right Cessation
- 1996-09-02 JP JP10509427A patent/JP2000513730A/ja not_active Withdrawn
- 1996-09-02 CN CNB961804068A patent/CN1165312C/zh not_active Expired - Lifetime
- 1996-09-02 SK SK112-99A patent/SK285849B6/sk not_active IP Right Cessation
- 1996-09-02 KR KR10-1999-7001057A patent/KR100440640B1/ko not_active Expired - Lifetime
- 1996-09-02 ES ES96928481T patent/ES2220986T5/es not_active Expired - Lifetime
- 1996-09-02 CA CA002262600A patent/CA2262600C/en not_active Expired - Lifetime
- 1996-09-02 HU HU0001020A patent/HU228301B1/hu not_active IP Right Cessation
- 1996-09-02 AT AT96928481T patent/ATE266408T1/de active
- 1996-09-02 DK DK96928481T patent/DK0871451T4/da active
- 1996-09-02 BR BRPI9612693A patent/BRPI9612693B8/pt not_active IP Right Cessation
- 1996-09-02 UA UA99021088A patent/UA66763C2/xx unknown
- 1996-09-10 ZA ZA967616A patent/ZA967616B/xx unknown
-
1999
- 1999-02-05 NO NO19990559A patent/NO326262B1/no not_active IP Right Cessation
- 1999-02-26 LT LT99-018A patent/LT4649B/lt not_active IP Right Cessation
- 1999-03-09 LV LVP-99-41A patent/LV12307B/en unknown
-
2003
- 2003-12-03 JP JP2003405151A patent/JP4554915B2/ja not_active Expired - Fee Related
-
2009
- 2009-02-04 JP JP2009024241A patent/JP2009102421A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI107015B (fi) | Kasvistanolirasvahappoestereiden seos ja sen käyttö sekä elintarvike | |
| US6025348A (en) | Oil and fat composition containing phytosterol | |
| JPH06506909A (ja) | 血清における高コレステロールレベルを低めるための物質及びその物質を調製するための方法 | |
| NO314357B1 (no) | Fytosterol og/eller fytosterolderivater | |
| US8512794B2 (en) | Oleate ester phytosterol compositions | |
| Clifton | Plant sterol and stanols—comparison and contrasts. Sterols versus stanols in cholesterol-lowering: is there a difference? | |
| US20030096035A1 (en) | Prepared foods containing triglyceride-recrystallized non-esterified phytosterols | |
| US8853191B2 (en) | Stanol composition and the use thereof | |
| RU2172629C2 (ru) | Станоловая композиция и ее применение | |
| MXPA99001350A (es) | Composicionde estanol y el uso de la misma | |
| NZ735207A (en) | Oil blends, processes for the preparation thereof and their use in formulas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assigment of application |
Owner name: RAISIO BENECOL OY |
|
| MA | Patent expired |